Distribution = promotionSchultz's limits on off-label

WASHINGTON - The second day of the Senate Labor and Human Resources Committee hearings on FDA reform last week focused on proposals to ease the agency's restrictions on dissemination by manufacturers of information about off-label uses of approved products.

In a partial concession to critics, who are calling for an end to FDA sanctions on distribution of peer-reviewed articles to physicians, the agency suggested that it be given the authority to review articles before they are sent to physicians.